2003
DOI: 10.1016/s1096-7176(03)00046-6
|View full text |Cite
|
Sign up to set email alerts
|

Genetic engineering of Escherichia coli for production of tetrahydrobiopterin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
33
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(34 citation statements)
references
References 17 publications
0
33
1
Order By: Relevance
“…2A) (Smith, 1987;Takikawa et al, 1986;Thony et al, 2000;Yamamoto et al, 2003). Even though the biosynthesis of BH4 in E. coli has been reported previously using a heterologous pathway (Yamamoto et al, 2003), we were not able to clone and express the SR gene in E. coli despite many attempts. This failure motivated us to (Ikemoto et al, 2002;Pribat et al, 2010).…”
Section: Resultsmentioning
confidence: 91%
See 1 more Smart Citation
“…2A) (Smith, 1987;Takikawa et al, 1986;Thony et al, 2000;Yamamoto et al, 2003). Even though the biosynthesis of BH4 in E. coli has been reported previously using a heterologous pathway (Yamamoto et al, 2003), we were not able to clone and express the SR gene in E. coli despite many attempts. This failure motivated us to (Ikemoto et al, 2002;Pribat et al, 2010).…”
Section: Resultsmentioning
confidence: 91%
“…BH4 biosynthesis requires two heterologous enzymes in addition to the endogenous GTP cyclohydrolase (FolE), which produces 7,8-dihydroneopterin triphosphate (H2-NPt-P3) from GTP: the 6-pyruvoyl-tetrahydropterin synthase (PTPS) catalyzes the conversion of H2-NPt-P3 to 6-pyruvoyltetrahydropterin (P-H4-Pt), and sepiapterin reductase (SR) performs the two-step reduction of the diketo intermediate P-H4-Pt to BH4 ( Fig. 2A) (Smith, 1987;Takikawa et al, 1986;Thony et al, 2000;Yamamoto et al, 2003). Even though the biosynthesis of BH4 in E. coli has been reported previously using a heterologous pathway (Yamamoto et al, 2003), we were not able to clone and express the SR gene in E. coli despite many attempts.…”
Section: Resultsmentioning
confidence: 99%
“…In addition to GDP-fucose, the modulation schemes of guanosine nucleotide biosynthesis in this work could also be used as references to improve the production of other bioactive substances, such as GDP-mannose [29,30], riboflavin [31,32] and tetrahydrobiopterin [33], biosynthesis of which also requires GTP as a precursor. With this optimal scheme, the GDP-fucose productivity was further improved by fed-batch fermentation to a maximum value of 6.6 ± 0.14 mol/g DCM, which corresponds to 3.9 mg/g DCM if GDP-fucose is presumed to exist as free acid (C 16 H 25 N 5 O 15 P 2 , Mw 589.34) and 4.2 mg/g DCM if existing as disodium salt as the commercial obtained GDP-fucose standard (C 16 H 23 N 5 Na 2 O 15 P 2 , Mw 633.31).…”
Section: Discussionmentioning
confidence: 99%
“…In mammals, GCYH-I is under negative-feedback inhibition through interactions with the GCYH feedback reg- VOL. 190, 2008 PRE-Q 0 BIOSYNTHESIS 7881 on May 11, 2018 by guest http://jb.asm.org/ ulatory protein (24), but this is not observed in bacteria as they lack this protein, and the overexpression of folate or BH4 biosynthetic genes results in overproduction of the final products (52,57). In E. coli, the expression of the folE gene has been shown to be under the control of the negative regulator MetJ (30).…”
Section: Discussionmentioning
confidence: 99%